Ved 24 uger var fald i HBV viral load signifikant større med entecavir (- 3, 65 vs en stigning på 0, 11 log10 kopier/ ml).
At 24 weeks the reduction in HBV viral load was significantly greater with entecavir (-3.65 vs an increase of 0.11 log10 copies/ ml).